Cannabis stocks hit some new highs on Wednesday ahead of what could be pivotal legislation in the form of the Marijuana Opportunity, Reinvestment, and Expungement, MORE Act, which the
Consolidation of the cannabis industry is inevitable as the market matures.
Heading into 2022, numerous forecasts predicted another flurry of M&A activity after an energized 2021. With nearly three months of the year complete, opinions are split on M&A activity so far.
BioSteel Sports Nutrition Inc., which is part-owned by Canopy Growth Corporation (NASDAQ: CGC) announced its latest athlete partnership with Sergiño Dest, defender for the U.S. Men’s National Soccer Team (USMNT).
New Jersey Senate president Nick Scutari (D) called delays in rolling out the state’s legal marijuana market unacceptable and is intending to form a special legislative committee to explore the issue through oversight hearings.
Over 20 cannabis industry CEOs attended the U.S. Cannabis Council's second CEO Summit in Washington D.C. just a few days ago. Benzinga got exclusive inside details on the meetings.
What Happened
CEOs from the following companies met in D.C. to lobby for cannabis reform:
Someone with a lot of money to spend has taken a bearish stance on Canopy Growth (NASDAQ:CGC).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.